Demant (DEMANT) Stock Price, Fundamentals & Analysis

What DEMANT does

Demant (DEMANT) is a hearing healthcare company that develops, manufactures, and distributes hearing aids, operates hearing care clinics, and provides hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics. The business spans Europe, North America, Asia, the Pacific region, and other international markets. Formerly known as William Demant Holding A/S, the company changed its name to Demant A/S in March 2019 and was founded in 1904. It is headquartered in Smørum, Denmark, and is part of the Nasdaq Copenhagen stocks index.

Key numbers explained

• 307,2 DKK is the current share price, representing the latest trading value of one share.
• The trailing P/E ratio of 26,7 shows how much investors pay per unit of the company's last 12 months' earnings; a higher number can reflect higher growth expectations.
• The forward P/E ratio of 19,3 uses expected future earnings and is often seen as a more forward-looking valuation measure.
• Dividend yield is 0%, meaning the company currently pays no cash dividend to shareholders.
• Beta of 0,76 suggests the stock has historically been less volatile than the overall market.
• 64,79B DKK is the market capitalisation, the total market value of all outstanding shares.
• 23,3% return on equity indicates how efficiently the company generates profit from shareholders' equity.
• 179,2% debt-to-equity shows that Demant carries more debt than equity, which is common in capital-intensive industries.

What to watch

Investors tracking Demant may also follow peers such as GN Store Nord (GN), which operates in the hearing devices space, and broader Danish healthcare names like Novo Nordisk (NOVO-B) and Coloplast (COLO-B). The stock's performance within the OMXC25 index can reflect broader Nordic market trends. Key factors to monitor include hearing aid technology developments, regulatory changes in medical devices, currency movements (given the DKK-denominated price), and the company's next earnings report on 11 aug. 2026.